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Abstract
Cells of the immune system routinely respond to cues from their local environment and feedback 
to their surrounding through transient responses, choice of differentiation trajectories, plastic 
changes in cell state, and malleable adaptation to their tissue of residence. Genomic approaches 
have opened the way for comprehensive interrogation of such orchestrated responses. Focusing on 
genomic profiling of transcriptional and epigenetic cell state, we discuss how they are applied to 
investigate immune cells faced with various environmental cues. We highlight some of the 
emerging principles, on the role of dense regulatory circuitry, epigenetic memory, cell type 
fluidity, and reuse of regulatory modules, in achieving and maintaining appropriate responses to a 
changing environment. These provide a first step toward a systematic understanding of molecular 
circuits in complex tissues.
Introduction
Homeostasis is a hallmark of biological systems that actively maintain a near-constant 
function in the face of a changing environment. In most animals, multiple systems, from the 
cellular to the organismal level, including the immune system, the nervous system and 
fibroblasts in connective tissue, play crucial homeostatic roles, as they sense, respond and 
adapt to an ever-changing environment – both external and intra-organismal – in different 
tissues in the body. In particular, the immune system achieves tunability, plasticity and 
adaptability to the environment at several levels (Figure 1). First, immune cells have 
transient responses to diverse factors, such as microbes, vaccines, tissue damage, or cancer 
cells (1). Second, controlled differentiation from progenitor cells generates different cell 
type balances (2). Furthermore, cells exhibit plasticity, such that certain immune cells can 
change their identity in the context of new signals (3, 4). Finally, cells can locate and 
relocate throughout the body, adapting their identity to their locale (1, 5).
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These abilities are controlled by a complex molecular circuitry, both intra-cellular (within 
immune cells) and through interaction amongst immune cells, or between immune cells and 
other cell types, including cells of the nervous system or fibroblasts. Malfunction in each of 
these mechanisms can contribute and give rise to disease. Manipulating them, in turn, 
provides important avenues for therapies, as has been the case in autoimmune disease and 
cancer. However, given the diversity of molecules, cell types and tissues, as well as the 
inherent uncertainties and noise in both molecular systems and measurement techniques, 
systematic dissection of these intra- and inter- cellular circuitries is remarkably challenging.
Genomics approaches have opened unique opportunities to address this challenge (Figure 2). 
Profiling of the genome, epigenome, transcriptome, proteome, and metabolome has been 
instrumental in defining cell types and states and characterizing the molecular changes that 
occur as cells respond to their surroundings. Recently, single cell genomics can distinguish 
these with remarkable resolution, even when the types and states of immune cells are not 
necessarily known (6–8), and when they are embedded in complex tissues (6, 9, 10) with 
spatial resolution (11–13). Profiling assays, especially of molecular interactions with ChIP-
Seq (14) and interaction proteomics help identify key aspects of the underlying molecular 
mechanisms – such as key transcription factors (TFs) and regulatory regions. To determine 
causality, large-scale perturbations, either engineered with RNAi and CRISPR-based 
genome editing (15), or natural variation between individuals in a population (16–19), 
provide a systematic mean to assess the causal role of different circuit components, 
including the context of disease in vivo.
While these assays can be applied in principle to many systems, analysis of immune cell 
responses has been at the forefront, providing a paradigm for other systems. First, the 
identity of many immune cell sub-types is known, and they can be isolated for analysis from 
both humans and mice; this has been critical, especially prior to the advent of single cell 
genomics. Furthermore, many primary immune cells can be studied both ex vivo and in vivo, 
including adoptive transfer of cells, bone marrow transplants and lineage tracing in animal 
models (6, 20, 21). Finally, immune cells are present throughout the body, differentiate 
continuously, and are implicated in many diseases, thus providing a broad lens into 
organismal physiology.
Here, we highlight the power of genomics to dissect environmental responses in immune 
cells. We focus on assays related to the regulation of mRNA expression, especially 
transcriptional and epigenetic profiling. Using macrophages and T cells as case studies, we 
illustrate the types of features that are underscored with different profiles, the resulting 
testable hypotheses that can be followed up in dedicated low-throughput experiments, and 
the emerging organizing principles (Figure 3). Finally, we discuss how these lessons, learned 
in immune cells, can be extended to develop approaches to dissect the overall function of 
diverse cells in maintaining homeostasis.
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Molecular responses of the immune system through transient intracellular 
circuits
Macrophages, innate immune cells of the myeloid lineage serve key immune defense 
functions through phagocytosis, and by communicating with adaptive immune cells through 
antigen presentation and secretion of and response to cytokines and chemokines (22–24). 
Mononuclear phagocyte subpopulations are located in the circulatory system and spleen and 
can differentiate into macrophages, but macrophages also reside in other tissues where they 
acquire specific characteristics and contribute to local hemostasis (1, 22, 23).
In their role as immune sensors, macrophages express pattern recognition molecules (e.g., 
Toll like receptors (TLR)), which detect conserved pathogen-associated or tissue damage-
associated molecular patterns, and mount the appropriate response. Genomic analysis of 
macrophages provided key insights on how these transient responses (Figure 1a) are carried 
out. For instance, transcriptional profiling along a time course following TLR4 activation 
with bacterial lipopolysaccharide (LPS), an inducer of inflammation, showed that genes are 
induced in several consecutive “waves” (25), a phenomenon observed in many other 
response systems (26) (Figure 3). The response waves are regulated through successive 
activation of transcriptional regulators (27, 28), whose identity can be predicted from DNA-
binding motifs enriched in the 5’ regions. This approach helped identify activating TF 3 
(ATF3) as an early regulator of the LPS response in macrophages (25). ATF3 was then 
shown to recruit histone deacetylase to repress its target genes – thus forming a negative 
feedback. This mechanism may be essential for controlling the extent and duration of TLR-
induced inflammation during infection, avoiding rampant inflammation and tissue damage.
The importance of epigenetic regulation as a way of controlling macrophage activation was 
further demonstrated by investigating the formation of “memory” in antigen-exposed 
macrophages (Figure 3) – where macrophages repeatedly exposed to a specific component 
(e.g., LPS) become tolerant, and selectively produce anti-microbial, but not pro-
inflammatory signals, to avoid tissue damage (27, 28). Profiling of gene expression and 
histone modifications (Figure 3) during the macrophage response to repeated stimulation 
reveals that tolerant genes that are not re-induced in repeated exposure to LPS are enriched 
for pro-inflammatory functions, and are transiently silenced by loss of activating histone 
marks. Conversely, non-tolerant genes are enriched for anti-microbial functions and are 
associated with a faster and stronger transcriptional response upon LPS re-stimulation 
(compared to the primary stimulation), through persistence or rapid acquisition of activating 
histone marks (H3 trimethylation and H4 acetylation respectively) and recruitment of RNA 
polymerase II (Pol II) and chromatin remodeling complexes. These distinct epigenetic 
mechanisms depend on the protein products generated during the first exposure to LPS, 
emphasizing the common role of negative feedback in controlling innate immune response 
(26, 29) (Figure 3).
Depending on their tissue of origin and stimulus, macrophages can acquire distinct 
functional states. Two well-studied states are pro-inflammatory M1 cells, derived in the 
presence of interferon gamma, and immuno-suppressive M2 cells that can be induced with 
interleukin 4 or 13 (30). Profiling the transcriptional response of monocyte-derived 
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macrophages to a more diverse set of stimuli suggests that macrophages can mount diverse 
transcriptional programs beyond these two states, depending on the metabolites, cytokines, 
and ligands to which they are exposed (30). Computational analyses of gene modules that 
are co-regulated across programs suggested that diversity between programs is generated by 
different combinations of active transcriptional regulators (Figure 3). Some of these 
regulators are “re-used” across all programs (e.g., the lineage specifying factor PU.1), 
whereas others are important only in certain contexts (e.g., STAT1 and STAT6, in the 
interferon gamma and interleukin 4 responses, respectively). Mapping the diverse activation 
programs also provided a way to decompose bulk samples into constituent responses, for 
instance, proposing that alveolar macrophages from chronic obstructive pulmonary disease 
patients are depleted in the inflammatory (M1) state, which may explain their poor response 
to anti-inflammatory therapeutics. Such analysis could further benefit from application of 
single-cell genomics (Figure 3).
Systematic perturbations have helped establish the causality of these observations. Causal 
loci were discovered either by associating natural genetic variation with variation in the 
transcriptional response across human individuals (16, 18, 19) or mouse strains (17), or by 
perturbing genes and measuring the effect on the transcriptome (15, 29).
Balanced differentiation from progenitor cells
The diverse cell types of the hematopoietic system are organized in a taxonomy along 
different lineages, and are produced daily from a small pool of stem cells (Figure 1b). The 
composition of hematopoietic cell subsets is tightly controlled, ensuring both homeostatic 
control and responsiveness to environmental cues. As in studies of transient immune 
responses, genomic and epigenomic profiling have shed light on the transcriptional shifts 
during hematopoiesis and the regulatory programs that govern them (Figure 3), primarily 
focusing on unperturbed, homeostatic conditions in humans (2, 31) and mice (14, 32). 
Transcriptional profiling revealed substantial expression changes between hematopoietic cell 
subtypes, comparable to those between different tissues (2). Computational analysis of these 
data, focused on “modules” of co-regulated genes and the regulators associated with them, 
has identified global organizing principles in hematopoiesis that may also apply more 
generally (Figure 3).
First, a large set of predicted transcriptional regulators (across all hematopoietic lineages) 
form a dense inter-connected network of regulatory interactions in each cell type, and with 
the same regulator used in multiple hematopoietic subsets. This organization may confer 
robustness, but could also be liable to dysregulation and cancer (2). This model challenged 
and expanded an earlier hierarchal model of hematopoiesis controlled by a small number of 
TFs, expressed sequentially (33).
Furthermore, there is no simple partitioning of regulatory activity at different lineages. 
Instead, entire modules of co-regulated genes, along with their upstream regulators are re-
used across distinct lineages, either because of shared functional needs in otherwise different 
cells (e.g., mitochondrial and oxidative phosphorylation in erythroid progenitors, 
granulocytes and monocytes (2)), or due to shared developmental descent. This latter pattern 
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is often reflected in “transitional” cases (Figure 3), with a gradual onset and offset of 
programs along the hematopoietic cell hierarchy (2). The transitional gene modules could be 
explained by either the presence of cells at different phases of development within 
seemingly pure populations of progenitor cells, or because regulatory programs of a more 
differentiated state are foreshadowed by pre-existing programs at earlier stages. Both models 
are plausible, and non-exclusive, the second model is strongly supported by profiling of TF 
binding in humans (2) and of chromatin organization in hematopoiesis in mice (14) and 
humans (31), where a large portion of the enhancers exhibited a “transitional” behavior – 
already established in the precursor cells, possibly in a poised (and transcriptionally 
inactive) state. Single cell RNA-Seq studies can help further address how transition to 
multiple lineages is concomitantly encoded in progenitor cells. To date, some studies 
suggested there may be distinct subsets within myeloid progenitor cells that are partially 
skewed towards distinct functional fates by the expression of key sub-lineage regulators 
(34), whereas others emphasized evidence for obligatory mixed-lineage states within the 
same single progenitor cell (35).
While it is tempting to think of hematopoiesis as stereotypic, differentiation is affected and 
driven by the environment, including not only the stromal niche and other immune cells, but 
also stress and pathogens (27, 36). For example, stress signals can lead to production of 
more innate immune myeloid cells at the expense of other lineages, especially lymphoid 
cells (36). Furthermore, distinct subpopulations of stem and progenitor cells can be activated 
(37) to produce cytokines that affect core immune responses. Genomic analysis, including at 
the single cell level, will shed more light on the regulation of hematopoiesis by such signals.
Plasticity of cell differentiation
As immune cells become more committed, differentiation and balancing between sub-
lineages become even more intertwined with environmental responses. For example, naïve T 
helper (Th) cells can differentiate into multiple specialized cell types, including conventional 
(Tconv) Th cells (e.g., Th1, Th2, Th17, Th9 cells) and regulatory Th cells (e.g., Treg, Tr1) 
(4). Given the diverse, and partially opposing functions of different Th cells (4), it is critical 
to maintain their correct blend, in a manner sensitive to and controlled by environmental 
signals. First, the relative proportion of Th subtypes that will develop from a limited pool of 
naive Th cells is regulated by the blend of cytokines to which a naive cell is exposed, often 
produced by antigen presenting cells (e.g., to Treg cells in the presence of TGF-s, but 
skewed to Th17 cells if interleukin 6 is also present). Second, while differentiated Th cell 
sub-types can be maintained stably over time, including in the memory pool (38), some can 
also transition into other, parallel sub-types (Figure 1c), depending on extra-cellular signals, 
from cytokines, to oxygen or nutrients (39), to components of the microbiome (3). The 
process leading to these diverse types is often called polarization, rather than terminal 
differentiation, and the change between the types is referred to as plasticity (1, 4), and can 
play critical physiological roles. For example, plastic polarization of tissue-resident 
macrophages helps fulfill changing functional demands from the tissue in which they reside 
(1, 40); Th cell plasticity could allow an organism to respond to a changing environment 
even if cells were originally committed to the memory pool in a different state (20).
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The distinction between a permanent and plastic state can be defined in principle, but 
challenging to identify in practice (41) because it can be hard to determine whether a stable 
state is permanent, and whether a cell’s expression of a marker of one type and functions of 
another is not mere noise (41). Genomic profiling coupled with lineage tracing and 
functional studies were instrumental in addressing these questions by defining the spectrum 
of cell states that can be attained by Th cells, the transition between states through 
differentiation and polarization, and the underlying regulatory mechanism (Figure 3).
Using the RNA profile of the cell as it’s functional identity, and coupled it to lineage tracing 
has helped identify both how a cell state it stably maintained and when it shifts plastically 
((20, 38, 42), reviewed in (4)). For example, Th17 cells can begin to express both cytokines 
and seminal TFs of other Th cells (20), but these could reflect either transition to another 
type, or a transient functional deviation. Lineage tracking of Th17 cells in the gut followed 
by RNA-Seq, showed that they can adopt a transcriptional signature of regulatory T cells 
and anti-inflammatory capacity. Conversely, tracing Th17 cells in a melanoma mouse model 
showed that while they can acquire transcriptional features of Th1 cells, they remain distinct 
from similarly traced Th1 cells, acquiring a stem-cell like signatures and longevity, with 
increased tumor eradication capacity (38).
While these studies profiled cell populations defined by cell surface, cytokine or TF 
expression, recent single cell genomic studies (6, 43) have increased the resolution at which 
we characterize cellular populations and their fluidity. For example, Th17 cells were shown 
to span a continuum of states, from higher expression of a program associated with 
pathogenic effect to one characteristic of regulatory cells, with distinct regulators for each 
program (6). Single cell RNA-Seq also provides a way for lineage tracing, by capturing the 
sequence of the T cell receptor transcript (10, 44, 45).
Profiling of chromatin organization, especially histone marks, across different Th cell types 
highlighted how epigenetic memory maintains cell state stably, while remaining sufficiently 
malleable to allow for plasticity (Figure 3). While signature cytokines often have a 
chromatin pattern congruent with strict cell type definitions, chromatin at other key signature 
genes of one lineage is not always repressed in other Th lineages, offering a possible basis 
for future plasticity. Indeed, chromatin marks and accessibility can change even for signature 
cytokines or TFs following stimulation (46). Conversely, DNA de-methylation and stable 
chromatin organization, with contribution from chromatin regulators and long non-coding 
RNAs, play an important role in stability. For instance, de-methylation of specific regulatory 
elements in a CpG island in the locus of Foxp3, a key regulator of Treg cells, helps 
stabilizing the cells’ identity, further reinforced by a transcriptional positive feedback loop 
(47). The ability of chromatin organization to function as a malleable memory device, is 
reflected by the preponderance of DNA variants associated with autoimmune disease that 
map to enhancer and other regulatory regions in Th cells (48).
Finally, RNA and TF ChIP-seq profiles, combined with genetic perturbations, have shed 
light on the intricate intracellular circuits controlling these processes in Treg (49) and 
inflammatory Th17 cells (50, 51). For example, in Th17 cells they revealed a “Yin-Yang” 
network of TFs, with two densely connected self-reinforcing, but mutually antagonistic, 
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modules: a larger module promotes the Th17 cell fate and suppresses alternative fates, and a 
smaller module has an opposite function. The dense, interconnected positive module 
provides stability; as has also been proposed for other Th lineages (42, 49). The smaller 
negative module could promote alternative plastic fates.
Malleable cell states mirror tissue location
Immune cells sense, adapt, respond to and affect their environment in the context of the 
tissue (Figure 1d). Tissue-resident immune cells, sometimes life-long sessile inhabitants, 
play critical roles in homeostasis and pathology, well beyond responses to pathogens. 
Tissue-resident macrophages perform unique functions as “accessory cell types” (1) that 
serve “client” primary cells defining the respective tissue. For example (1, 23), alveolar 
macrophages are critical for surfactant homeostasis in the lungs, microglia are essential for 
synaptic pruning in the brain, osteoclasts are critical for the dynamic balance of bone, and 
splenic red-pulp macrophages help manage heme and iron from aging red blood cells. 
Tissue-resident Tregs (5) have been identified in visceral adipose tissue (VAT) (52, 53), the 
intestine (54), muscle (55), and lung (56), with roles from metabolic homeostasis to tissue 
repair and regeneration.
Genomic analysis has played a critical role in identifying tissue-resident immune cells, 
characterizing their unique features, determining their tissue-specific functions, and inferring 
the principles and mechanisms by which they adapt to the diversity of tissues in the body 
and their changing local conditions.
RNA profiling has identified the level at which immune cells of a single “type” vary given 
their tissue-of-residence (Figure 3). In addition to a core set of macrophage-associated 
genes, tissue resident macrophages (18, 21, 40, 57) express distinct gene modules in each 
tissue type. For example, brain-resident microglia (which are deposited prenatally), develop 
lock-step with the rest of the CNS during brain development and are susceptible to 
environmental signals pre-natally (58). Tregs isolated from different tissues have shown a 
similar distinctions (52–55). The profiles and derived signatures then become the fingerprint 
of the cell’s identity, and – when coupled to transfer, chimera or lineage tracing experiments 
– can establish if a cell is stably resident in a tissue (52). They also allow us to follow their 
clonal expansion in response to stimulus. It is possible that other immune lineages may also 
follow such principles; single cell profiling of entire tissues (9, 10) will help determine this.
Individual genes expressed in these tissue-specific modules – including TFs, cytokines, 
chemokines and receptors – provide critical starting points to determine the cells’ functions 
(e.g., lipid metabolism in Tregs in VAT (53), regulatory mechanisms (e.g., Gata6 in 
peritoneal macrophages (57)), and interaction with other tissue cell (e.g., Treg-adipocyte 
interaction through IL10 (53)). The exquisite tunability reflected by these programs, led in 
turn to the exploration of how they are diversely yet stably imprinted on a cell type based on 
its local environment (1). Two distinct mechanisms (or a blend thereof) can in principle 
underlie this phenomenon: a pre-programmed set of states, both preceding and succeeding 
tissue residence; and/or an environmentally-directed process, either permanent (tissue-
resident differentiation) or signal-dependent (plasticity).
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Epigenomic analysis of macrophages from different tissues strongly supports the signal-
dependent model. Tissue resident macrophages have distinct enhancer landscapes compared 
to promoters, with a large number of unique, tissue-specific, poised and active enhancers. 
These enhancers can be substantially – albeit not completely – reprogrammed by 
environment-specific signals in either bone marrow transplant, tissue transfer experiments or 
ex vivo manipulations (18, 21). As for Th cell plasticity, differential enhancer usage may 
underlie the preponderance of genetic variants associated with human immune disease in 
enhancer regions (48).
Combinatorial regulation by TFs helps in turn to establish transcriptional programs for tissue 
resident macrophages. During differentiation, a first layer of lineage determining “pioneer” 
factors delineates cell-type specific enhancers through nucleosome repositioning and 
recruitment of histone modifying enzymes; after differentiation, a second layer of signal-
dependent factors binds in those pre-existing loci. Some enhancers are shared across all 
tissue resident macrophages (18, 21), but are only poised, and signal-dependent factors 
modulate the activity of this pre-existing enhancer repertoire to achieve context-dependent 
gene expression. Other enhancers are formed “de novo” to create epigenetic memory of 
tissue-residence. Thus, signal-dependent (40), tissue-specific TFs can either work 
cooperatively with the macrophage pioneer factor PU.1 to form new enhancers or can 
activate poised enhancers that have been formed and pre-bound by Pu.1. This mechanism 
can also account for transient tissue-resident programs.
Tissue-specific Tregs also exhibit cooperation between tissue-specific and lineage-specific 
factors (18, 21, 40, 53). For example, PPARγ, the master regulator of adipocyte 
differentiation, is the key regulator of the tissue specific program in visceral adipose tissue 
(VAT) Tregs (53). PPARγ in adipose tissue Tregs responds to the tissue’s signal of insulin 
and orchestrates the relevant metabolic response, mediated through the same biochemical 
and molecular mechanisms as in adipocytes. It is tempting to speculate that this intracellular 
“molecular mirroring” between two different cell types in a single tissue, could help 
synchronize not only their response to signal but also how this signal is precisely processed 
and affects the same output modules, beyond what could be achieved by inter-cellular 
communication alone. Such mirroring could exist between other cell types in tissue, immune 
and non-immune.
Perspective: Towards a tissue circuit
The cellular environment is interwoven into a single integrated whole in tissues, bringing 
together diverse cell types – epithelial, immune, neurons, stromal and more – as they 
differentiate and respond to each other, microbes, nutrients, and other stimuli. These 
responses can be transient, permanent or plastic, and include migration. Every aspect of this 
“tissue circuit”, including the proportion of cell types, and their states, function and 
interactions, changes as the local environment varies.
Dissecting how cells interact to maintain tissue function requires knowing the census of cell 
types and states, their biological roles in the tissue, the signals received and emitted by each 
cell and their effects, and the cascade of events underlying dynamic tissue processes. 
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Addressing these questions requires the ability to profile the individual cells that comprise 
the tissue, consider their spatial position and physical interactions in faithful biological 
samples, have computational means to reconstruct molecular-level quantitative models that 
combine intra-cellular with inter-cellular circuits, and functional means to test them. Recent 
technological breakthroughs – in single cell genomics (59) spatially resolved profiling (12, 
13), systematic genetic perturbations (15), and access to tissue biopsies and orgnaoids 
provide promising steps in that direction.
Analysis at a whole-tissue level should provide an unprecedented view into the cellular and 
molecular composition of tissues and an understanding of the molecular and functional 
interactions by which cells cooperate to fulfill tissue function and maintain homeostasis. 
Ultimately, such an understanding will have the potential to be translated to exceptionally 
effective new therapies that can restore tissue function and human health.
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Figure 1. Key modes of immune-environment interaction
A) Transient responses to signals. (B) Balanced differentiation along hematopoiesis; (C) 
Stable yet plastic cell type polarization; (D) Malleable adaptation of tissue resident cells.
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Figure 2. Genomic tools for dissecting immune-environment interactions
Shown are key components of the current genomic tool box, including profiling of RNA, 
protein and protein modification levels in bulk samples (A) and single cells (B), epigenomic 
measurements of TF binding, histone modification, DNA methylation, and chromatin 
accessibility (C), the ability to systematically perturb genes through genome engineering (D) 
or natural variation, tracing of cells with engineered molecular barcodes or TcR and BcR 
clonality (E), and computational algorithms that use profiling and perturbation data to infer 
genetic causality and molecular mechanisms (F).
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Figure 3. Key features, hypotheses and principles revealed by genomic studies of immune-
environment interactions
Three key genomic tools used to analyze transcription and epigenetic mechanisms that 
participate in immune cell responses. Bottom: The main features characterized by each tool, 
testable hypotheses derived by computational analysis; and current emerging principles from 
such studies.
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